Edwards Lifesciences Corporation Share Price
Equities
EW
US28176E1082
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 81.64 USD | -2.68% |
|
-4.96% | -4.23% |
| Capitalization | 48.72B 42.01B 37.92B 36.39B 66.35B 4,478B 69.44B 448B 180B 2,147B 183B 179B 7,680B | P/E ratio 2026 * |
29.1x | P/E ratio 2027 * | 26.5x |
|---|---|---|---|---|---|
| Enterprise value | 44.17B 38.09B 34.38B 32.99B 60.16B 4,060B 62.96B 406B 163B 1,947B 166B 162B 6,963B | EV / Sales 2026 * |
6.62x | EV / Sales 2027 * | 5.82x |
| Free-Float |
89.32% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Edwards Lifesciences Corporation
| 1 day | -2.68% | ||
| 1 week | -4.96% | ||
| Current month | -5.59% | ||
| 1 month | +4.53% | ||
| 3 months | -5.28% | ||
| 6 months | +0.86% | ||
| Current year | -4.23% |
| 1 week | 80.5 |  | 87.32 |
| 1 month | 74.66 | | 87.32 |
| Current year | 74.66 | | 87.32 |
| 1 year | 65.94 | | 87.89 |
| 3 years | 58.93 | | 96.12 |
| 5 years | 58.93 | | 131.73 |
| 10 years | 27.04 | | 131.73 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 58 | 10/05/2023 | |
Scott Ullem
DFI | Director of Finance/CFO | 59 | 31/12/2013 |
Todd Brinton
CTO | Chief Tech/Sci/R&D Officer | - | 31/01/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 69 | 06/05/2024 | |
Kieran Gallahue
BRD | Director/Board Member | 62 | 09/02/2015 |
| Director/Board Member | 58 | 10/05/2023 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | -4.39% | 2.46% | 54 M€ | |
| -1.01% | 2.34% | 26 M€ | |
| -2.55% | 1.17% | 25 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.68% | -4.96% | +12.07% | -0.34% | 48.72B | |
| -3.25% | -3.49% | -4.24% | -10.27% | 193B | |
| -1.32% | -3.30% | -13.71% | +108.69% | 176B | |
| -3.22% | -6.62% | -7.15% | -22.77% | 143B | |
| -2.25% | -5.81% | -31.86% | +49.21% | 108B | |
| -0.22% | -4.67% | -23.73% | -19.98% | 52.25B | |
| -0.96% | -1.63% | +12.97% | +15.04% | 37.19B | |
| -3.68% | -11.50% | -12.38% | -2.75% | 35.14B | |
| -2.57% | -4.88% | -9.04% | -20.05% | 33.38B | |
| -4.14% | -6.29% | -20.15% | -7.45% | 30.96B | |
| Average | -1.00% | -2.16% | -9.72% | +8.93% | 85.79B | |
| Weighted average by Cap. | -0.62% | -1.89% | -10.77% | +20.71% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.67B 5.75B 5.19B 4.98B 9.08B 613B 9.5B 61.36B 24.58B 294B 25.03B 24.5B 1,051B | 7.33B 6.32B 5.7B 5.47B 9.98B 673B 10.44B 67.4B 27B 323B 27.49B 26.91B 1,155B |
| Net income | 1.67B 1.44B 1.3B 1.25B 2.28B 154B 2.39B 15.4B 6.17B 73.77B 6.28B 6.15B 264B | 1.82B 1.57B 1.42B 1.36B 2.48B 168B 2.6B 16.78B 6.72B 80.37B 6.84B 6.7B 287B |
| Net Debt | -4.55B -3.92B -3.54B -3.4B -6.19B -418B -6.48B -41.85B -16.77B -200B -17.07B -16.71B -717B | -6.1B -5.26B -4.75B -4.56B -8.31B -561B -8.7B -56.16B -22.5B -269B -22.91B -22.42B -962B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/03/26 | 81.64 $ | -2.68% | 5,132,827 |
| 05/03/26 | 83.89 $ | -1.56% | 6,404,836 |
| 04/03/26 | 85.22 $ | -0.07% | 4,439,290 |
| 03/03/26 | 85.28 $ | -2.18% | 5,594,225 |
| 02/03/26 | 87.18 $ | +0.82% | 3,749,413 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- EW Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition